Literature DB >> 9927494

Biologic significance of angiopoietin-2 expression in human hepatocellular carcinoma.

S Tanaka1, M Mori, Y Sakamoto, M Makuuchi, K Sugimachi, J R Wands.   

Abstract

Human hepatocellular carcinoma (HCC) is generally a highly vascular tumor, but the mechanisms of neovascularization that permit rapid growth have not been defined. Angiopoietins (Ang) recently have been identified as ligands for vascular endothelial-specific Tie2 receptor tyrosine kinase and may be important growth factors in the generation of new blood vessels. We investigated Ang expression in 23 samples of HCC and paired adjacent uninvolved liver samples to determine if these genes have a potential role in the growth and spread of this disease. The full coding sequence of a variant angiopoietin-2 (Ang2) cDNA was obtained from HCC specimens, and the biologic consequences of overexpression on tumor formation and hemorrhage were determined in an animal model system. Angiopoietin-1 (Ang1) was equally expressed in HCC and adjacent noncarcinomatous liver tissue. Surprisingly, Ang2 was found to be highly expressed only in tumor tissue. In addition, Ang2 was expressed in 10 of 12 hypervascular HCC, but only in 2 of 11 hypovascular HCC. Ectopic expression of Ang2 in nonexpressing HCC cells promotes the rapid development of human hepatomas and produces hemorrhage within tumors in nude mice. These results suggest a role for Ang2 in the neovascularization of HCC. This enhanced gene expression may contribute to the clinical hypervascular phenotype, as well as tumor formation and progression.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9927494      PMCID: PMC407900          DOI: 10.1172/JCI4891

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  20 in total

1.  A carboxy-terminal truncated insulin receptor substrate-1 dominant negative protein reverses the human hepatocellular carcinoma malignant phenotype.

Authors:  S Tanaka; J R Wands
Journal:  J Clin Invest       Date:  1996-11-01       Impact factor: 14.808

Review 2.  The implications of angiogenesis for the biology and therapy of cancer metastasis.

Authors:  I J Fidler; L M Ellis
Journal:  Cell       Date:  1994-10-21       Impact factor: 41.582

3.  Distinct roles of the receptor tyrosine kinases Tie-1 and Tie-2 in blood vessel formation.

Authors:  T N Sato; Y Tozawa; U Deutsch; K Wolburg-Buchholz; Y Fujiwara; M Gendron-Maguire; T Gridley; H Wolburg; W Risau; Y Qin
Journal:  Nature       Date:  1995-07-06       Impact factor: 49.962

Review 4.  Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis.

Authors:  D Hanahan; J Folkman
Journal:  Cell       Date:  1996-08-09       Impact factor: 41.582

5.  tie2, a putative protein tyrosine kinase from a new class of cell surface receptor.

Authors:  A S Runting; S A Stacker; A F Wilks
Journal:  Growth Factors       Date:  1993       Impact factor: 2.511

6.  Primary liver cancer in Japan. Clinicopathologic features and results of surgical treatment.

Authors: 
Journal:  Ann Surg       Date:  1990-03       Impact factor: 12.969

7.  GRB2 and SH-PTP2: potentially important endothelial signaling molecules downstream of the TEK/TIE2 receptor tyrosine kinase.

Authors:  L Huang; C W Turck; P Rao; K G Peters
Journal:  Oncogene       Date:  1995-11-16       Impact factor: 9.867

8.  Anti-transforming growth factor (TGF)-beta antibodies inhibit breast cancer cell tumorigenicity and increase mouse spleen natural killer cell activity. Implications for a possible role of tumor cell/host TGF-beta interactions in human breast cancer progression.

Authors:  C L Arteaga; S D Hurd; A R Winnier; M D Johnson; B M Fendly; J T Forbes
Journal:  J Clin Invest       Date:  1993-12       Impact factor: 14.808

9.  The endothelial-specific receptor tyrosine kinase, tek, is a member of a new subfamily of receptors.

Authors:  D J Dumont; G J Gradwohl; G H Fong; R Auerbach; M L Breitman
Journal:  Oncogene       Date:  1993-05       Impact factor: 9.867

10.  Dominant-negative and targeted null mutations in the endothelial receptor tyrosine kinase, tek, reveal a critical role in vasculogenesis of the embryo.

Authors:  D J Dumont; G Gradwohl; G H Fong; M C Puri; M Gertsenstein; A Auerbach; M L Breitman
Journal:  Genes Dev       Date:  1994-08-15       Impact factor: 11.361

View more
  54 in total

1.  The role of the vascular phase in solid tumor growth: a historical review.

Authors:  D Ribatti; A Vacca; F Dammacco
Journal:  Neoplasia       Date:  1999-10       Impact factor: 5.715

Review 2.  Angiogenesis, thrombospondin, and ductal carcinoma in situ of the breast.

Authors:  A Rice; C M Quinn
Journal:  J Clin Pathol       Date:  2002-08       Impact factor: 3.411

Review 3.  Mathematical modeling of tumor-induced angiogenesis.

Authors:  Nikos V Mantzaris; Steve Webb; Hans G Othmer
Journal:  J Math Biol       Date:  2004-02-06       Impact factor: 2.259

Review 4.  Current status of molecularly targeted therapy for hepatocellular carcinoma: basic science.

Authors:  Shinji Tanaka; Shigeki Arii
Journal:  Int J Clin Oncol       Date:  2010-05-27       Impact factor: 3.402

Review 5.  Current status and perspective of antiangiogenic therapy for cancer: hepatocellular carcinoma.

Authors:  Shinji Tanaka; Shigeki Arii
Journal:  Int J Clin Oncol       Date:  2006-04       Impact factor: 3.402

Review 6.  Application of angiogenesis to clinical dermatology.

Authors:  Levi E Fried; Jack L Arbiser
Journal:  Adv Dermatol       Date:  2008

Review 7.  Putative effects of potentially anti-angiogenic drugs in rheumatic diseases.

Authors:  Nicola Maruotti; Francesco Paolo Cantatore; Domenico Ribatti
Journal:  Eur J Clin Pharmacol       Date:  2013-11-07       Impact factor: 2.953

Review 8.  Hepatocellular carcinoma--cause, treatment and metastasis.

Authors:  Z Y Tang
Journal:  World J Gastroenterol       Date:  2001-08       Impact factor: 5.742

9.  Expression of angiopoietin-2 gene and its receptor Tie2 in hepatocellular carcinoma.

Authors:  L Chen; Z Yang; G Wang; C Wang
Journal:  J Tongji Med Univ       Date:  2001

10.  Angiopoietin-1 causes reversible degradation of the portal microcirculation in mice: implications for treatment of liver disease.

Authors:  Nicole L Ward; Alexandra L Haninec; Paul Van Slyke; John G Sled; Celina Sturk; R Mark Henkelman; Ian R Wanless; Daniel J Dumont
Journal:  Am J Pathol       Date:  2004-09       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.